Trials / Active Not Recruiting
Active Not RecruitingNCT07291583
Hyaluronic Acid With Connective Tissue Grafting for Gingival Recession
Clinical and Aesthetic Evaluation of Hyaluronic Acid in Addition to Connective Tissue Grafts in the Treatment of Gingival Recession Defects
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Saglik Bilimleri Universitesi · Academic / Other
- Sex
- All
- Age
- 18 Months
- Healthy volunteers
- Not accepted
Summary
This study evaluates whether adding 0.8% hyaluronic acid (HA) to connective tissue grafting and coronally advanced flap surgery improves clinical and esthetic outcomes in the treatment of gingival recession. Adult patients with Miller I-II or Cairo RT1 recession defects will be randomly assigned to receive CTG alone or CTG with adjunctive HA. Mean root coverage at 6 months is the primary outcome, while secondary measures include gingival thickness, clinical attachment level, esthetic scores, postoperative morbidity, and quality of life. The study aims to determine whether HA enhances soft tissue healing and root coverage predictability compared with conventional CTG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Hyaluronic Acid (0.8%) - Applied over CTG before flap closure (Test group only). | A 0.8% hyaluronic acid (HA) gel is applied to the connective tissue graft (CTG) before flap closure during the coronally advanced flap (CAF) procedure. The HA gel is used as an adjunctive biologic material to potentially enhance wound healing, soft tissue thickness, esthetic outcomes, and overall root coverage performance |
| PROCEDURE | Connective Tissue Graft + Coronally Advanced Flap (CTG + CAF) | A standardized coronally advanced flap (CAF) procedure combined with a subepithelial connective tissue graft (CTG) is performed to treat gingival recession defects. The surgical protocol includes flap elevation, graft harvesting and placement, and flap advancement and suturing. |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-01-01
- Completion
- 2026-07-01
- First posted
- 2025-12-18
- Last updated
- 2025-12-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07291583. Inclusion in this directory is not an endorsement.